The Patent Finder

Shanghai Chempartner Co., Ltd.

Also on record
Records under this name other than patents Shanghai Chempartner Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Shanghai Chempartner Co., Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,980,829Aryl Glycoside Compound, Preparation Method and Use Thereof
In force
 · High confidence
In forceHigh confidence
US 9,487,4903-Cyclohexenyl AND CYCLOHEXYL SUBSTITUTED INDOLE AND INDAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
conveyed to Merck Sharp and Dohme Corp. - now held by Merck Sharp & Dohme LLC
In force
 · High confidence
In forceHigh confidence
US 9,556,168N-ALKYLATED INDOLE AND INDAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
conveyed to Merck Sharp and Dohme Corp. - now held by Merck Sharp & Dohme LLC
In force
 · High confidence
In forceHigh confidence
US 9,663,5223-Aminocycloalkyl COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
conveyed to Merck Sharp and Dohme Corp. - now held by Merck Sharp & Dohme LLC
In force
 · High confidence
In forceHigh confidence
US 9,745,2654-Heteroaryl SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
conveyed to Merck Sharp and Dohme Corp. - now held by Merck Sharp & Dohme LLC
In force
 · High confidence
In forceHigh confidence
US 10,196,3544-Heteroaryl Substituted Benzoic Acid Compounds as Rorgammat Inhibitors and Uses Thereof
conveyed to Merck Sharp and Dohme Corp. - now held by Merck Sharp & Dohme LLC
In force
 · High confidence
In forceHigh confidence
US 9,730,940Purine Inhibitors of Human Phosphatidylinositol 3-Kinase Delta
conveyed to Merck Sharp and Dohme Corp. - now held by Merck Sharp & Dohme LLC
In force
 · High confidence
In forceHigh confidence
US 9,938,281Purine Inhibitors of Human Phosphatidylinositol 3-Kinase Delta
conveyed to Merck Sharp and Dohme Corp. - now held by Merck Sharp & Dohme LLC
In force
 · High confidence
In forceHigh confidence
US 9,708,347Heterobicyclo-Substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine Compounds with A2A Antagonist Properties
conveyed to Merck Sharp and Dohme Corp. - now held by Merck Sharp & Dohme LLC
In force
 · High confidence
In forceHigh confidence
US 9,676,780Piperazine-Substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine Compounds with A2A Antagonist Properties
conveyed to Merck Sharp and Dohme Corp. - now held by Merck Sharp & Dohme LLC
In force
 · High confidence
In forceHigh confidence
10 of 26 records shown.
Pro members see all 26.
Pro members: see all 26 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited